摘要
目的探讨纤溶酶联合血塞通治疗急性脑梗死的临床疗效。方法将80例急性脑梗死患者随机分为对照组和治疗组,每组40人。对照组给予血塞通治疗14天,治疗组给予纤溶酶联合血塞通治疗14天,评定两组临床效果。结果两组总有效率比较差异有统计学意义(均P<0.05)。结论纤溶酶联合血塞通治疗急性脑梗塞的疗效优于单用血塞通。
Objective To explore the clinical effect of fibrinogenase and Xuesaitong injection on acute cerebral infarction.Methods 80 cases of acute cerebral infarction were randomly divided into the control group and the treatment group,40 cases in each group.The control group was treated with Xuesaitong injection for 14 days,but the treatment group was treated with fibrinogenase and Xuesaitong injection for 14 days.Then the clinical effects of two groups were evaluated.Results There were significant differences between the control group and the treatment group on the total effective rate equal（P0.05）.Conclusion The effect of fibrinogenase and Xuesaitong injection was better than that of Xuesaitong injection on acute cerebral infarction.
出处
《当代医学》
2011年第11期58-59,共2页
Contemporary Medicine
关键词
纤溶酶
血塞通
急性脑梗死
Fibrinogenase
Xuesaitong injection
Acute cerebral infarction
